<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Holgersen Park | Activity</title>
	<link>https://recash.wpsoul.net/members/chimetoy34/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/chimetoy34/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Holgersen Park.</description>
	<lastBuildDate>Tue, 19 May 2026 20:03:20 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">378cad24cf0fecec82aff05fa881d1dc</guid>
				<title>Holgersen Park posted an update: Treatment of steroid-refractory chronic graft-versus-host [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/57680/</link>
				<pubDate>Thu, 12 Dec 2024 08:07:45 +0000</pubDate>

									<content:encoded><![CDATA[<p>Treatment of steroid-refractory chronic graft-versus-host disease (cGVHD) is a challenge. Here, we describe a retrospective analysis of 66 patients with steroid-refractory cGVHD treated with imatinib (starting dose of 100 mg in 70% of patients; maximum dose of 100-200 mg in 74%). Most patients had multi-organ involvement (≥2 organs, 83%), with t&hellip;<span class="activity-read-more" id="activity-read-more-57680"><a href="https://recash.wpsoul.net/activity/p/57680/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5936811aaf29619cb77c2b0b710ed19d</guid>
				<title>Holgersen Park became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/51296/</link>
				<pubDate>Wed, 11 Dec 2024 15:09:25 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>